Taisho Pharmaceutical Co., Ltd.

Japan


 
Total IP 869
Total IP incl. subs 873 (+ 5 for subs)
Total IP Rank # 1,531
IP Activity Score 3.3/5.0    346
IP Activity Rank # 2,079
Parent Entity Otsuka Holdings Co., Ltd.
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

210 108
76 2
447 17
9
 
Last Patent 2025 - 2'-deoxy-2',2'-difluorotetrahydr...
First Patent 1976 - Method for preparing 17 .alpha.-...
Last Trademark 2025 - TEXIPY
First Trademark 1982 - LIPOVITAN

Subsidiaries

1 subsidiaries with IP (1 patents, 4 trademarks)

2 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treat...
Invention Sulfonamide compounds and use thereof. The present disclosure relates to novel crystalline forms...
Invention Anti-tumor agent containing taxane compound, and anti-tumor effect enhancer. In order to provide...
Invention Combination decitabine and cedazuridine solid oral dosage forms. Embodiments of the present inve...
Invention Chemotherapy for cancer using azabicyclo compound. Provided are a novel cancer treatment method ...
Invention Method of treating malignant tumor by azabicyclic compound. Provided is a method of treating mal...
Invention Combination therapy using azabicyclo compound for cancer. Provided is a novel method for treatin...
G/S Anti-cancer preparations; pharmaceutical preparations for the treatment of tumor; chemical reagen...
Invention L718 and/or l792 mutant treatment-resistant egfr inhibitor. The present invention provides an an...
Invention 2'-deoxy-2',2'-difluorotetrahydrouridines with high purity and methods of making the same. The i...
2024 Invention Brain-migrating tumor treatment agent containing, as active ingredient, n-(4-(4-amino-6-ethynyl-5...
G/S Pharmaceutical preparations for use in dermatology, wounds, treating diabetes, analgesics, eye-wa...
Invention Crystals of 7h-pyrrolo[2,3-d]pyrimidin-4-amine derivatives. Crystalline forms of N-(4-(4-amino-6-...
Invention Methods of treating cancer using futibatinib, pembrolizumab and at least one additional chemother...
Invention Cancer therapy including 3,5-disubstituted benzene alkynyl compound and immune checkpoint inhibit...
Invention Cancer combination therapy using aza bicyclic compound and antiandrogen agent. Provided is a nove...
Invention Treatment methods for subjects with non-small cell lung cancer having an aberration in egfr. A me...
Invention Crystal of quinoline-substituted compound. The present invention addresses the problem of providi...
Invention Pharmaceutical composition. The purpose of the present invention is to provide a pharmaceutical c...
Invention Prophylactic drug/therapeutic drug for progressive supranuclear palsy. Provided is a novel prophy...
Invention Antibody-drug conjugate containing anti-cd138 antibody. Provided is an antibody-drug conjugate (A...
Invention Ftd-tpi combination preparation, pd-1 pathway antagonist, and combination use of vegf pathway ant...
Invention Method for treating cancer patients with severe renal impairment. A method for treating cancer i...
2023 Invention Crystals of acetate hydrochloride. The present invention provides I form crystals of 4-piperidiny...
Invention Selective inhibitor of exon 20 insertion mutant egfr. An antitumor agent comprising a compound s...
Invention Methods of treating cancer using futibatinib and pembrolizumab. The present disclosure relates to...
Invention Cancer therapy using 3,5-disubstituted benzene alkynyl compound and immune checkpoint inhibitor. ...
Invention 5h-pyrrolo[2,3-d]pyrimidin-6(7h)-one and crystal of salt thereof. Provided is a type-I crystal of...
Invention Pharmaceutical composition containing pimitespib. Provided is a pharmaceutical composition contai...
Invention Analogues of azabicyclic compounds. Provided are novel compounds which are analogues to be remove...
G/S Advertising and publicity services; business management analysis and business consultancy; busine...
Invention Method for producing 7h-pyrrolo[2,3-d]pyrimidine-4-amine derivative. The present invention provid...
Invention Ph-dependent anti-sulfated glycosaminoglycan antibody and antibody-drug conjugate. This invention...
Invention Ph-dependent anti-sulfated glycosaminoglycan antibody and antibody-drug conjugate. This inventio...
Invention Crystal form of cyclohexenone compound. An object of the present disclosure is to provide a crys...
Invention Crystal form of cyclohexenone compound. An object of the present disclosure is to provide a cryst...
2022 Invention Combination therapies for treatment of t-cell lymphomas with tolinapant, cedazuridine and decitabine
Invention Process for preparing a benzoate salt of a 1-(3-aminopyrrolidine-1-carbonyl)-3,4-diphenylbenzene ...
Invention Treatment methods for subjects having cancer with a dysregulated mapk and/or pi3k pathway. A met...
Invention Anti-growth hormone antibody. In one embodiment, the present invention provides an antibody spec...
Invention New juniper pollen protein. The present disclosure relates to a juniper pollen protein selected ...
Invention Small molecule inhibitors of kras mutated proteins. Compounds of Formula (I) or their pharmaceut...
Invention Treatment methods for subjects with cancer having an aberration in egfr and/or her2. A method of...
Invention Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2- hydroxy-2-eth...
Invention Treating cancer in patient with pten inactivating mutation. A method of treating a subject with ...
2021 Invention Brain-migrating tumor therapeutic agent containing fused pyrimidine compound as active ingredient...
Invention Crystalline forms of 4-amino-n-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinop...
Invention Methods of using 4-amino-n-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholinoprop-...
Invention Methods of treating ribonucleotide reductase-related diseases with a ribonucleotide reductase inh...
Invention Treating cancer in patient having co-occurring genetic alteration in fgfr2 and a cancer driver ge...
G/S Application software; computer programs; electronic machines, apparatus and their parts; smartph...
G/S Downloadable application software for processing images, graphics and text; downloadable computer...
G/S Pharmaceutical, veterinary and sanitary preparations; dietary supplements for medical purposes; D...
G/S Anti-cancer preparations; pharmaceutical preparations for the treatment of tumors; chemical reage...
2020 Invention Polypeptide having mmp2-inhibitory effect. The present invention provides a substituted polypept...